12 May 2020
Learning what’s dangerous is costly, but social animals have a way of lowering the price
For social animals, such as humans, being able to recognize the presence of a threat in the behavior of others could literally be a life-saver. Yet, animals do not instinctively know that when a group member displays freezing – one of the three universal defense responses – it means trouble. Now, new findings by the Behavioural Neuroscience Lab demonstrate how animals acquire this ability and identify the neural circuitry crucial for implementing it.
29 Apr 2020
Champalimaud Investigator receives Award to explore how the immune and nervous systems control lung infection
Henrique Veiga-Fernandes is the first Portuguese investigator selected for a CZI (Chan Zuckerberg Initiative) grant. The project, selected for the Single-Cell Analysis of Inflammation grant, comprises a team of three prominent scientists that will join forces to unravel neuro-immune interactions and their potential therapeutic contributions to pulmonary infection and inflammation.
06 Apr 2020
Follow your gut: Newly identified digestive-brain axis controls food choice
We may try to consciously make good food choices, but our bodies have their own way of weighing in. A new study reveals a learning mechanism orchestrated by the digestive and nervous systems that leads animals to actively seek out certain foods. These results are a step towards understanding how eating-related disorders, such as obesity, occur.
01 Apr 2020
Six "la Caixa" Foundation Junior Leadership awarded to CCU, IGC and ITQB researchers
“la Caixa” Foundation Junior Leadership call, an internationally competitive call aiming to attract and maintain internationally competitive researchers of any nationality to Portugal and Spain.
30 Mar 2020
CF team retains over 1.25M euros for Artificial Intelligence for Health Imaging project
The Champalimaud Foundation is pleased to announce that ProCAncer-I: An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum, submitted to the Horizon 2020 DT-TDS-05-2020 topic, has been retained for funding with an amazing score of 15 out of 15 points.
17 Dec 2019
Zebrafish “avatars” can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients. This is a significant problem as patients may be unnecessarily subjected to potentially severe side effects. A new assay offers a promising solution with rapid, personalized radiotherapy compatibility testing, using zebrafish as avatars.